{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:10:15Z","timestamp":1792440615877,"version":"4.5.0"},"reference-count":39,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"8","funder":[{"name":"Canadian National Transplant Research Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2019,8,2]]},"abstract":"<jats:p>Toxicity from the immunosuppressant mycophenolate mofetil is prevented by eliminating gut bacteria expressing \u03b2-glucuronidase.<\/jats:p>","DOI":"10.1126\/sciadv.aax2358","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:15:54Z","timestamp":1565205354000},"source":"Crossref","is-referenced-by-count":125,"title":["Vancomycin relieves mycophenolate mofetil\u2013induced gastrointestinal toxicity by eliminating gut bacterial \u03b2-glucuronidase activity"],"prefix":"10.1126","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0651-0848","authenticated-orcid":true,"given":"Michael R.","family":"Taylor","sequence":"first","affiliation":[{"name":"Departments of Pediatrics and Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Alberta Children\u2019s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle L.","family":"Flannigan","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3740-2735","authenticated-orcid":true,"given":"Hannah","family":"Rahim","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Alberta Children\u2019s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6529-7181","authenticated-orcid":true,"given":"Amina","family":"Mohamud","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Alberta Children\u2019s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5753-499X","authenticated-orcid":true,"given":"Ian A.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5782-1481","authenticated-orcid":true,"given":"Simon A.","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-1720","authenticated-orcid":true,"given":"Steven C.","family":"Greenway","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Alberta Children\u2019s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."},{"name":"Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-014-1247-1"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1097\/01.tp.0000186383.22264.b3","article-title":"Review of major clinical trials with mycophenolate mofetil in cardiac transplantation","volume":"80","author":"Kobashigawa J. A.","year":"2005","unstructured":"J. A. Kobashigawa, B. M. Meiser, Review of major clinical trials with mycophenolate mofetil in cardiac transplantation. Transplantation 80, S235\u2013S243 (2005).","journal-title":"Transplantation"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.semdp.2014.02.007","article-title":"Drug-induced injury in the gastrointestinal tract","volume":"31","author":"Panarelli N. C.","year":"2014","unstructured":"N. C. Panarelli, Drug-induced injury in the gastrointestinal tract. Semin. Diagn. Pathol. 31, 165\u2013175 (2014).","journal-title":"Semin. Diagn. Pathol."},{"key":"e_1_3_2_5_2","first-page":"366","article-title":"Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation","volume":"28","author":"Calmet F. H.","year":"2015","unstructured":"F. H. Calmet, A. J. Yarur, G. Pukazhendhi, J. Ahmad, K. R. Bhamidimarri, Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation. Ann. Gastroenterol. 28, 366\u2013373 (2015).","journal-title":"Ann. Gastroenterol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation","volume":"14","author":"Knoll G. A.","year":"2003","unstructured":"G. A. Knoll, I. MacDonald, A. Khan, C. Van Walraven, Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J. Am. Soc. Nephrol. 14, 2381\u20132386 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/FPC.0000000000000010","article-title":"PharmGKB summary: Mycophenolic acid pathway","volume":"24","author":"Lamba V.","year":"2014","unstructured":"V. Lamba, K. Sangkuhl, K. Sanghavi, A. Fish, R. B. Altman, T. E. Klein, PharmGKB summary: Mycophenolic acid pathway. Pharmacogenet. Genomics 24, 73\u201379 (2014).","journal-title":"Pharmacogenet. Genomics"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1074\/jbc.R116.767434","article-title":"Glucuronides in the gut: Sugar-driven symbioses between microbe and host","volume":"292","author":"Pellock S. J.","year":"2017","unstructured":"S. J. Pellock, M. R. Redinbo, Glucuronides in the gut: Sugar-driven symbioses between microbe and host. J. Biol. Chem. 292, 8569\u20138576 (2017).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.01.035"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fcvm.2017.00017","article-title":"Changes in composition of the gut bacterial microbiome after fecal microbiota transplantation for recurrent Clostridium difficile infection in a pediatric heart transplant patient","volume":"4","author":"Flannigan K. L.","year":"2017","unstructured":"K. L. Flannigan, T. Rajbar, A. Moffat, L. S. McKenzie, F. Dicke, K. Rioux, M. L. Workentine, T. J. Louie, S. A. Hirota, S. C. Greenway, Changes in composition of the gut bacterial microbiome after fecal microbiota transplantation for recurrent Clostridium difficile infection in a pediatric heart transplant patient. Front. Cardiovasc. Med. 4, 17 (2017).","journal-title":"Front. Cardiovasc. Med."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.healun.2018.05.002","article-title":"An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil","volume":"37","author":"Flannigan K. L.","year":"2018","unstructured":"K. L. Flannigan, M. R. Taylor, S. K. Pereira, J. Rodriguez-Arguello, A. W. Moffat, L. Alston, X. Wang, K. K. Poon, P. L. Beck, K. P. Rioux, M. Jonnalagadda, P. K. Chelikani, H. J. Galipeau, I. A. Lewis, M. L. Workentine, S. C. Greenway, S. A. Hirota, An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil. J. Heart Lung Transplant. 37, 1047\u20131059 (2018).","journal-title":"J. Heart Lung Transplant."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1034\/j.1399-0012.2000.140301.x","article-title":"Intravenous mycophenolate mofetil: Safety, tolerability, and pharmacokinetics","volume":"14","author":"Pescovitz M. D.","year":"2000","unstructured":"M. D. Pescovitz, D. Conti, J. Dunn, T. Gonwa, P. Halloran, H. Sollinger, S. Tomlanovich, S. Weinstein, S. Inokuchi, B. Kiberd, D. Kittur, R. M. Merion, D. Norman, A. Shoker, R. Wilburn, A. J. Nicholls, S. Arterburn, E. Dumont, Intravenous mycophenolate mofetil: Safety, tolerability, and pharmacokinetics. Clin. Transplant. 14, 179\u2013188 (2000).","journal-title":"Clin. Transplant."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40268-018-0254-8","article-title":"Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?","volume":"18","author":"Gardiner K. M.","year":"2018","unstructured":"K. M. Gardiner, S. E. Tett, C. E. Staatz, Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life? Drugs R D 18, 271\u2013282 (2018).","journal-title":"Drugs R D"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001492"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JB.180.14.3495-3502.1998","article-title":"What\u2019s for dinner?: Entner-Doudoroff metabolism in Escherichia coli","volume":"180","author":"Peekhaus N.","year":"1998","unstructured":"N. Peekhaus, T. Conway, What\u2019s for dinner?: Entner-Doudoroff metabolism in Escherichia coli. J. Bacteriol. 180, 3495\u20133502 (1998).","journal-title":"J. Bacteriol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw383"},{"issue":"2","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1093\/cid\/civ252","article-title":"Differences of the fecal microflora With Clostridium difficile therapies","volume":"60","author":"Louie T. J.","year":"2015","unstructured":"T. J. Louie, B. Byrne, J. Emery, L. Ward, W. Krulicki, D. Nguyen, K. Wu, K. Cannon, Differences of the fecal microflora With Clostridium difficile therapies. Clin. Infect. Dis. 60 (Suppl. 2), S91\u2013S97 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2017.05.003"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.005414"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2676"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.27"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1038\/s41598-017-03252-4","article-title":"Real-time imaging of intestinal bacterial \u03b2-glucuronidase activity by hydrolysis of a fluorescent probe","volume":"7","author":"Chen M.","year":"2017","unstructured":"M. Chen, K.-W. Cheng, Y.-J. Chen, C.-H. Wang, T.-C. Cheng, K.-C. Chang, A.-P. Kao, K.-H. Chuang, Real-time imaging of intestinal bacterial \u03b2-glucuronidase activity by hydrolysis of a fluorescent probe. Sci. Rep. 7, 3142 (2017).","journal-title":"Sci. Rep."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1097\/TP.0b013e31820a6a79","article-title":"Pharmacokinetic drug interaction of mycophenolate with co-amoxiclav in renal transplant patients","volume":"91","author":"Ratna P.","year":"2011","unstructured":"P. Ratna, B. S. Mathew, V. M. Annapandian, K. Saravanakumar, G. Basu, V. Tamilarasi, D. H. Fleming, Pharmacokinetic drug interaction of mycophenolate with co-amoxiclav in renal transplant patients. Transplantation 91, e36\u2013e38 (2011).","journal-title":"Transplantation"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/bdd.1894","article-title":"Inhibitory effect of ciprofloxacin on \u03b2-glucuronidase-mediated deconjugation of mycophenolic acid glucuronide","volume":"35","author":"Kodawara T.","year":"2014","unstructured":"T. Kodawara, S. Masuda, Y. Yano, K. Matsubara, T. Nakamura, M. Masada, Inhibitory effect of ciprofloxacin on \u03b2-glucuronidase-mediated deconjugation of mycophenolic acid glucuronide. Biopharm. Drug Dispos. 35, 275\u2013283 (2014).","journal-title":"Biopharm. Drug Dispos."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"45088","DOI":"10.1038\/srep45088","article-title":"The immunosuppressant mycophenolic acid alters nucleotide and lipid metabolism in an intestinal cell model","volume":"7","author":"Heischmann S.","year":"2017","unstructured":"S. Heischmann, M. Dzieciatkowska, K. Hansen, D. Leibfritz, U. Christians, The immunosuppressant mycophenolic acid alters nucleotide and lipid metabolism in an intestinal cell model. Sci. Rep. 7, 45088 (2017).","journal-title":"Sci. Rep."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.yexcr.2014.01.021","article-title":"Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions","volume":"322","author":"Qasim M.","year":"2014","unstructured":"M. Qasim, H. Rahman, R. Ahmed, M. Oellerich, A. R. Asif, Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions. Exp. Cell Res. 322, 277\u2013289 (2014).","journal-title":"Exp. Cell Res."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"C1378","DOI":"10.1152\/ajpcell.1997.273.4.C1378","article-title":"Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation","volume":"273","author":"Turner J. R.","year":"1997","unstructured":"J. R. Turner, B. K. Rill, S. L. Carlson, D. Carnes, R. Kerner, R. J. Mrsny, J. L. Madara, Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am. J. Physiol. 273, C1378\u2013C1385 (1997).","journal-title":"Am. J. Physiol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fphys.2017.00438","article-title":"MPA modulates tight junctions\u2019 permeability via Midkine\/PI3K pathway in Caco-2 cells: a possible mechanism of leak-flux diarrhea in organ transplanted patients","volume":"8","author":"Khan N.","year":"2017","unstructured":"N. Khan, L. Binder, D. V. K. Pantakani, A. R. Asif, MPA modulates tight junctions\u2019 permeability via Midkine\/PI3K pathway in Caco-2 cells: a possible mechanism of leak-flux diarrhea in organ transplanted patients. Front. Physiol. 8, 438 (2017).","journal-title":"Front. Physiol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.3748\/wjg.v16.i42.5272","article-title":"Non-invasive markers of gut wall integrity in health and disease","volume":"16","author":"Derikx J. P. M.","year":"2010","unstructured":"J. P. M. Derikx, M. D. P. Luyer, E. Heineman, W. A. Buurman, Non-invasive markers of gut wall integrity in health and disease. World J. Gastroenterol. 16, 5272\u20135279 (2010).","journal-title":"World J. Gastroenterol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1191175"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"e65519","DOI":"10.1371\/journal.pone.0065519","article-title":"Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategy","volume":"8","author":"Jonnalagadda M.","year":"2013","unstructured":"M. Jonnalagadda, C. E. Brown, W.-C. Chang, J. R. Ostberg, S. J. Forman, M. C. Jensen, Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategy. PLOS ONE 8, e65519 (2013).","journal-title":"PLOS ONE"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201310-351OC"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02772-10"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3869"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm864"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00127-16"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.f.303"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac1021166"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"G1288","DOI":"10.1152\/ajpgi.00341.2012","article-title":"Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice","volume":"303","author":"Asano Y.","year":"2012","unstructured":"Y. Asano, T. Hiramoto, R. Nishino, Y. Aiba, T. Kimura, K. Yoshihara, Y. Koga, N. Sudo, Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G1288\u2013G1295 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aax2358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T12:19:10Z","timestamp":1704802750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aax2358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8,2]]}},"alternative-id":["10.1126\/sciadv.aax2358"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aax2358","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/561274","asserted-by":"object"}]},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"article-number":"eaax2358"}}